MTRAC for Life Sciences Innovation Hub, based at U-M Medical School, awards annual funding to 11 project teams
ANN ARBOR, Mich. — From an innovative coating for joint replacements, to a promising drug for the painful inflammatory disease scleroderma, 11 new biomedical ideas that emerged from research across Michigan have just gotten funding that could help them make the leap from lab to patient care.
Over $2 million in funding has just flowed to the teams developing these concepts from the Michigan Translational Research and Commercialization for Life Sciences Innovation Hub. MTRAC, as it’s known, is co-managed by the University of Michigan Medical School and Office of Research with funding from U-M and the Michigan Economic Development Corporation. .
Projects from across the state were selected for funding by MTRAC’s Innovation Hub team, to accelerate their paths to market, bringing them one step closer to ultimately helping patients and their families.
To read more about the program and funded projects, click here.